Jefferies Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-145,610
Closed -$871K 2631
2013
Q4
$871K Sell
145,610
-76,717
-35% -$355K 0.01% 891
2013
Q3
$1.15M Buy
+222,327
New +$974K 0.01% 847

Jefferies Group's IDIX Position: Q1 2014 in Review

Jefferies Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q1 2014, closing a stake of 145,610 shares — an estimated $871K sold.

Jefferies Group first reported a position in IDIX in Q3 2013 and held it in 2 quarters. The position peaked at $1.15M in Q3 2013. 96 funds tracked by Wall St. Rank hold IDIX as of Q1 2014.

  • Jefferies Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Jefferies Group sold 145,610 IDENIX PHARMACEUTICALS INC shares in Q1 2014, an estimated $871K.
  • Jefferies Group first reported a position in IDENIX PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
  • Jefferies Group's IDENIX PHARMACEUTICALS INC position peaked at $1.15M in Q3 2013.
  • 96 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q1 2014.

Based on Jefferies Group's 13F filing for Q1 2014, filed 16 May 2014.